A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Clinical trial NCT05169684 · TERMINATED

Trial details

NCT number: NCT05169684
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms, Castration-Resistant

Start date: 2022-02-14
Primary completion: 2023-12-06
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.